ResearcherUniversity of Chicago Medical CenterNo recent work listed

Tong‐Chuan He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7721-3934; OpenAlex author ID A5070578608. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2018: 1 paper

Papers 1

Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Last author DOI 10.1038/s41598-018-36214-5 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bing Peng · 1 shared paper, 2018 · strength 0.06
- Paper Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR … DOI 10.1038/s41598-018-36214-5 ↗
Bo Huang · 1 shared paper, 2018 · strength 0.06
- Paper Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR … DOI 10.1038/s41598-018-36214-5 ↗
Xin Wang · 1 shared paper, 2018 · strength 0.06
- Paper Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR … DOI 10.1038/s41598-018-36214-5 ↗
Xubao Liu · 1 shared paper, 2018 · strength 0.06
- Paper Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR … DOI 10.1038/s41598-018-36214-5 ↗
Zhenyu Ye · 1 shared paper, 2018 · strength 0.06
- Paper Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR … DOI 10.1038/s41598-018-36214-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.